Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
POSTED
05-25-23
Alejandro Pliego’s Journey Into STEM
Alejandro Pliego is attending Princeton, class of 2027. He is smart and poised, but Princeton was hardly a foregone conclusion. The child of immigrants from Cuernavaca, Mexico, he is the first member of his family to go to college.
POSTED
04-28-23
Breeding Better Sugar With Genomics
Folk wisdom says that putting sugar in someone’s gas tank will ruin their car. Truth is, not only is that a myth, with a few extra steps, sugarcane can be turned into ethanol, a greener alternative to fossil fuels.
POSTED
04-25-23
Sequencing at Sea – Unlocking the Power of the Genome With eDNA and NextSeq™ 2000
In 2022, Illumina and Minderoo Foundation announced a $40M AUD partnership to leverage the power of genomics to accelerate scientific understanding of marine systems and help marine conservationists make informed decisions.
POSTED
04-20-23
Singapore’s Best Employers 2023: Illumina Singapore Illustrates a ‘Culture of Care’
Flexible time off, critical care leave, mentorship programmes and a week-long company-wide shutdown are just some of the policies that biotech company Illumina Singapore offers its 1,800 employees here.
POSTED
04-19-23
Illumina Celebrates "Save the Smile of the Yangtze River" Charity Walk in China
From March 23rd to March 29th, a total of 206 Illumina colleagues in Greater China walked to support the recovery of the endangered species, finless porpoise population, and the healthy development of the Yangtze River ecosystem by donating their walking steps.
POSTED
04-18-23
The African Continent Ramps Up Efforts To Crack the Code on Outbreaks
On a recent afternoon in Nairobi, Kenya, about two dozen scientists gathered, peering at a screen that to the untrained eye looked like gibberish — rows of letters but no coherent words.
POSTED
04-12-23
Local Teachers Spread Passion for STEM with SD2/Illumina Corporate Foundation STEM Educators Award
The 2022 SD2 and Illumina Corporate Foundation STEM Educator Awards have been awarded to local San Diego educators Hannah Nakamoto, a chemistry and physics teacher at Kearny High School, and Mario Patiño, a middle and high school science teacher at the Preuss School at UCSD.
POSTED
04-07-23
Illumina Rings the Bell at Nasdaq
The Nasdaq closing bell in New York City signifies the end of a full day of trading on the stock market, a day of transactions made to benefit shareholders and companies, and propel business forward. Fittingly, Illumina representatives rang the closing bell on March 30.
POSTED
04-06-23
ACEGID and Illumina to Increase Africa’s Genomics Capacity through Establishment of a Joint Training Academy
The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, announced that it will collaborate with Illumina on a joint workforce development training academy, with the objective of increasing Africa’s genomics capacity.
POSTED
04-05-23
25 Greatest Impacts in 25 Years: Illumina and the Evolution of Genomics
This month, Illumina celebrates a quarter century of innovation, research, and passion. As a genomics pioneer founded in San Diego in 1998, we have proven—and continue to prove—how unlocking the power of the genome can exponentially improve the human condition.
